Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The path to self-management: a qualitative study involving older people with multiple sclerosis.
Removing confounding factors via constraint-based clustering: An application to finding homogeneous groups of multiple sclerosis patients.
Prevalence of stress urinary incontinence in women with multiple sclerosis.
The next generation of exoskeletons: lighter, cheaper devices are in the works.
Correlation of nitric oxide levels in the cerebellum and spinal cord of experimental autoimmune encephalomyelitis rats with clinical symptoms.
T-cell vaccination in Crohn's disease: principles and presentation of the first two cases.
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials.
Do neutralising antibodies against exogenous interferon-beta inhibit endogenous signalling pathways?
The attributable burden of panic disorder in the impairment of quality of life in a national survey in Italy.
Enrollment complete for cannabinoid MS study
Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord.
Transverse myelitis.
Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination.
Alteration of CD1 expression in multiple sclerosis.
Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy.
SymptoMScreen: A Tool for Rapid Assessment of Symptom Severity in MS Across Multiple Domains.
Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamide.
Biogen Idec to present new two-year data from the PLEGRIDY™ (peginterferon beta-1a) Phase III advance study at AAN annual meeting
Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.
Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
High-dose cyclophosphamide in the treatment of multiple sclerosis.
Solitary sclerosis: progressive myelopathy from solitary demyelinating lesion. A new entity?
Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis.
Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE.
The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers.

Pages